Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMSAM: 113 Adverse Event Reports & Safety Profile

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain
113
Total FAERS Reports
0
Deaths Reported
1
Hospitalizations
113
As Primary/Secondary Suspect
1
Life-Threatening

First Report: 200607 · Latest Report: 20140412

What Are the Most Common EMSAM Side Effects?

#1 Most Reported
Depression
19 reports (16.8%)
#2 Most Reported
Application site erythema
17 reports (15.0%)
#3 Most Reported
Drug ineffective
14 reports (12.4%)

All EMSAM Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Depression 19 16.8% 0 0
Application site erythema 17 15.0% 0 0
Drug ineffective 14 12.4% 0 0
Insomnia 11 9.7% 0 0
Application site pruritus 10 8.9% 0 0
Anxiety 9 8.0% 0 0
Drug effect decreased 9 8.0% 0 0
Headache 9 8.0% 0 0
Nausea 9 8.0% 0 0
Dizziness 8 7.1% 0 0
Application site rash 7 6.2% 0 0
Rash 6 5.3% 0 0
Wrong technique in drug usage process 6 5.3% 0 0
Application site irritation 5 4.4% 0 0
Fatigue 5 4.4% 0 0

Who Reports EMSAM Side Effects? Age & Gender Data

Average age: 55.2 years. Most reports from: US. View detailed demographics →

Is EMSAM Getting Safer? Reports by Year

YearReportsDeathsHosp.
2006 1 0 0
2011 2 0 0
2012 7 0 0
2013 71 0 0
2014 2 0 0

View full timeline →

What Is EMSAM Used For?

IndicationReports
Depression 71
Major depression 16
Anxiety 5

EMSAM vs Alternatives: Which Is Safer?

EMSAM vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE EMSAM vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL EMSAM vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE EMSAM vs EMTRICITABINE\TENOFOVIR DISOPROXIL EMSAM vs ENALAPRIL EMSAM vs ENALAPRIL\HYDROCHLOROTHIAZIDE EMSAM vs ENALAPRIL\LERCANIDIPINE EMSAM vs ENASIDENIB EMSAM vs ENCORAFENIB EMSAM vs ENOXAPARIN

Official FDA Label for EMSAM

Official prescribing information from the FDA-approved drug label.